Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04958889 · ClinicalTrials.gov registry record
COVID-19 Recovery Study: Symptoms and Biomarkers of Long COVID-19 in People Living With and Without HIV
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 392
- Enrollment target
NCT04958889: Completed study, sponsored by Johns Hopkins University.
NCT04958889 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 392 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04958889 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 392 participants
- Enrollment target
Study Summary
This observational study will prospectively characterize the long-term symptoms and side effects of COVID-19 in cohorts of people living with and without HIV. This will be achieved through a series of remote study visits involving completing surveys about health history, symptoms, mood, quality of life and changes in health, and up to two blood draws from home through the use of a mobile phlebotomy service.
Primary Outcome
Time to return to usual health and activities, as measured using the Influenza Patient-reported Outcome (Flu-PRO) instrument. The overall score is calculated as the mean across 32 items, and ranges from 0 (symptom free) to 4 (very severe symptoms).
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 392 participants |
| Start Date | 2021-06-11 |
| Est. Completion | 2024-03-31 |
What the finished NCT04958889 record still lists
NCT04958889 is an observational study that tracks outcomes without assigning an intervention. The registered 392 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT04958889 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04958889 about?
NCT04958889 is a clinical study titled "COVID-19 Recovery Study: Symptoms and Biomarkers of Long COVID-19 in People Living With and Without HIV". This observational study will prospectively characterize the long-term symptoms and side effects of COVID-19 in cohorts of people living with and without HIV. This will be achieved through a series of remote study visits involving completing surveys about health history, symptoms, mood, quality of l...
What is the current status of trial NCT04958889?
This trial is currently completed. The enrollment target is 392 participants. The study started on 2021-06-11. Estimated completion is 2024-03-31.
What interventions are being tested in trial NCT04958889?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT04958889?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06397703 · 392 participants · Phase 2
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer
- NCT06625775 · 392 participants · Phase 1
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- NCT07220967 · 392 participants · Phase 4
A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement
- NCT07290036 · 392 participants · Phase 1
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI